Company profile
DUB Therapeutics
anti-fibrotic self-delivering siRNAs (sdRNA)
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- Syracuse, New York
- Founded
- 2022
- LinkedIn followers
- 448
- Office locations
- 2
DUB Therapeutics company summary
DUB Therapeutics is a company in the Biotechnology Research industry, headquartered in Syracuse, New York, founded in 2022. On LinkedIn the company has around 6 employees and 448 followers. The company lists 2 office locations.
What technology does DUB Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About DUB Therapeutics
DUB Therapeutics is a preclinical biotechnology company developing anti-fibrotic self-delivering siRNAs across multiple therapeutic areas. We are proud to share that we have been recognized by the American Academy of Ophthalmology for our innovative approach using our novel anti-fibrotic self-delivering siRNA (sdRNA) technology in the treatment of ocular surface diseases and procedures. We look forward to sharing our plans for improving quality of life for millions of patients living with fibrotic diseases worldwide.
Where is DUB Therapeutics located?
DUB Therapeutics lists 2 office locations.
Compare companies similar to DUB Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
DUB Therapeutics dubtherapeutics.com | Biotechnology Research | 6 | 2022 | Syracuse, New York |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about DUB Therapeutics
What does DUB Therapeutics do?
DUB Therapeutics is a preclinical biotechnology company developing anti-fibrotic self-delivering siRNAs across multiple therapeutic areas. We are proud to share that we have been recognized by the American Academy of Ophthalmology for our innovative approach using our novel anti-fibrotic self-delivering siRNA (sdRNA) technology in the treatment of ocular surface diseases and procedures. We look forward to sharing our plans for improving quality of life for millions of patients living with fibrotic diseases worldwide.
How many employees does DUB Therapeutics have?
DUB Therapeutics has around 6 employees on LinkedIn.
Where is DUB Therapeutics headquartered?
DUB Therapeutics is headquartered in Syracuse, New York.
Where does DUB Therapeutics have offices?
DUB Therapeutics lists 2 office locations, including Syracuse, New York, US.
When was DUB Therapeutics founded?
DUB Therapeutics was founded in 2022.
Build a lead list from companies like DUB Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.